Ingelvac Provenza™: The Real Cost of IAV-S
Clayton Johnson, DVM Director of Health, Carthage Veterinary Service
Hear from Clayton Johnson, DVM, about performance loss and the widespread impact of influenza A virus in swine (IAV-S) on profitability.
Clayton Johnson, DVM Director of Health, Carthage Veterinary Service
Hear from Clayton Johnson, DVM, about performance loss and the widespread impact of influenza A virus in swine (IAV-S) on profitability.
WELCOME TO INGELVACPROVENZA.COM
This is a required field
This website is an international information resource intended for veterinarians who are interested in information about Ingelvac Provenza™ and influenza A virus in swine.
While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that the registration status and approved product label may not be the same in different countries.
INGELVAC PROVENZA™ IS ONLY CURRENTLY LICENCED IN THE UNITED STATES OF AMERICA. Information on this website is derived from the product label in the USA.
By checking the box below, you are declaring and confirming that you are a veterinarian professional and that you have read and understood this disclaimer.
You must accept the terms and conditions and data policy to enter the website
Ingelvac Provenza is a trademark of Boehringer Ingelheim Vetmedica GmbH. © 2018 Boehringer Ingelheim Vetmedica, Inc.